Accéder au contenu
Merck

Flupirtine-induced hepatic failure requiring orthotopic liver transplant.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation (2011-08-09)
Fritz Klein, Matthias Glanemann, Birgit Rudolph, Daniel Seehofer, Peter Neuhaus
RÉSUMÉ

We present the case of a 48-year-old otherwise healthy man who required an urgent liver transplant owing to acute liver failure after flupirtine treatment. After 3 months of daily flupirtine intake as treatment for pseudoradicular pain syndrome, he presented at our institution with signs of jaundice and hepatic encephalopathy. Laboratory results showed elevated liver transaminases, and the liver histopathology supported the assumed drug-induced liver injury. After listing him for an urgent liver transplant, he was given a liver graft from a 21-year-old man. Despite a rejection episode on day 11 after the surgery (which was successfully treated by steroid pulse therapy), the postoperative course was uneventful and the patient recovered completely. To the best of our knowledge, this is the first report of a liver transplant for acute liver failure after taking flupirtine.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Flupirtine maleate salt, ≥98% (HPLC)